Clinical Trial

Microangiopathy in Diabetes

Study acronym: MIND
Recruiting
View on ClinicalTrials.gov →
Summary
This clinical trial aims to evaluate the use of a contactless and non-invasive technique to measure the properties of the skin's microcirculation and its regulatory functions in both healthy individuals and patients with microvascular disease associated with type 1 diabetes. It is hoped that the study results will lead to the development of a useful method for detecting diabetic complications at an early stage, thereby enabling treatment and preventive measures before the onset of severe microangiopathy.
Trial Details
NCT Number NCT07145567
Lead Sponsor Karolinska Institutet
Collaborators: Neko Health AB
Conditions Microangiopathy, Microvascular Complications
Enrollment 400 participants
Start Date 2024-03-01
Primary Completion 2027-06 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2025-08-28